Clinical Trial Update: Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating triple therapy to prevent recurrent intracerebral hemorrhage events has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Intracerebral Hemorrhage

Snippet

Sponsor: The George Institute | Conditions: Intracerebral Haemorrhage (ICH), Hypertension | Phase 3 | Status: COMPLETED